Colonoscopy test for Parkinson's disease detection
Part of Brain & nervous system clinical trials.
This study tests whether a protein in colon tissue can help diagnose Parkinson's disease. People with Parkinson's who already need a routine colonoscopy may participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 99 years old
- You have a confirmed diagnosis of Parkinson's disease
- You are scheduled for a routine colonoscopy for cancer screening or other reasons
- You are not taking blood thinners (except Plavix 75 mg or aspirin up to 325 mg)
- You do not have a history of colon cancer
- You are not pregnant or planning to become pregnant before the colonoscopy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies nerve cell “biomarkers” from the gut to learn whether they can help detect Parkinson’s disease (or related conditions) earlier. You may be asked to undergo a colonoscopy to collect gut tissue for testing.
This trial uses a small piece of colon tissue, taken during a routine colonoscopy, to look for a protein linked to Parkinson's disease and REM sleep behavior disorder (RBD). It aims to improve diagnosis for these conditions.
This study looks at the germs in your gut and certain chemicals they make, which may relate to Parkinson's disease. It compares people with Parkinson's to healthy people of similar age and body size to see if there are differences.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study looks for a new blood marker that could help doctors detect Parkinson’s disease earlier. Depending on your diagnosis and treatment status, your blood may be compared with other people’s to see how well the test works.
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.